The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck

Cancer

Volumn 91, Issue 12, 2001, Pages 2343-2352

  Kim, Gwi Eon ^a   Yang, Woo Ick ^a   Lee, Sang Wook ^a   Kim, Yong Bae ^a   Suh, Chang Ok ^a   Yoon, Joo Heon ^b   Oh, Young Taik ^a   Chung, Hyun Cheol ^c   Kim, Byung Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Angiocentric lymphoma; Granzyme B; Immunohistochemical study; Natural killer T cell lymphoma

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; GRANZYME B; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD56; BIOLOGICAL MARKERS; FEMALE; GRANZYMES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOMA; MALE; MIDDLE AGED; SERINE ENDOPEPTIDASES; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME;

EID: 0035876193     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010615)91:12<2343::AID-CNCR1267>3.0.CO;2-3     Document Type: Article

References (40)

1. Midline malignant reticulosis (so-called lethal midline granuloma)
2. The protean clinical features of polymorphic reticulosis (lethal midline granuloma)
3. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases
4. Angiocentric immunoproliferative lesions: A molecular analysis of eight cases
5. A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group
6. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis and epidermiology
7. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses-an immunohistochemical study
8. Nasal T-cell lymphoma: A clinicopathological and immunophenotypic analysis of 13 cases
9. Expression of natural killer cell markers in non-Hodgkin's lymphomas
10. CD56+ putative natural killer cell lymphomas: Production of cytolytic effectors and its proteins mediating tumor cell apoptosis?
11. Subtype of Epstein-Barr virus in malignant lymphoma in Korea
12. Nasal T-cell lymphoma a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
13. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity
14. Natural killer-like T cell lymphoma; aggressive lymphomas of T-large granular lymphocytes
15. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
16. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement
17. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
18. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas
19. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas
20. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation
21. Perforin and granzyme expression in cytotoxic T-cell lymphomas
22. Granzyme B-expressing peripheral lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization
23. Granzyme B immunoreactivity in T/natural killer cell lymphomas
24. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease
25. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin
26. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue
27. TIA-1 expression in lymphoid neoplasms: Identification of subsets with cytotoxic T-lymphocyte or natural killer cell differentiation
28. Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells
29. Characterization of three serine proteases isolated from human IL-2 activated killer cells
30. Characterization of granzyme A and B isolated from granules of cloned human cytotoxic T lymphocytes
31. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins
32. Localization and identification of granzyme A and B-expressing cells in normal human lymphoid tissue and peripheral blood
33. Perforin and serine esterase gene expression in stimulated human T cells: Kinetics, mitogen requirement and effects of cyclosporin A
34. Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK)
35. Granzymes; exogeneous proteinases that induce target cell apoptosis
36. Granule serine proteases are normal nuclear constituents of natural killer cells
37. Cytotoxic T-lymphocyte granules are secretory lysosomes, containing both perforin and granzymes
38. Morphologic and functional analysis of PTA granules in human NK cells
39. New insight into peripheral T-cell lymphomas